Cromolyn sodium 2 % / xylometazoline HCl 0.025 % Nasal Spray
RxNorm 830585
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 830585 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cromolyn sodium 2 % / xylometazoline HCl 0.025 % Nasal Spray.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Cromolyn sodium 20 mg/ML / xylometazoline 0.25 mg/ML Nasal Spray
(Atom ID: 12342200)
PSN
Prescribable Name (PSN):
Cromolyn sodium 2 % / xylometazoline HCl 0.025 % Nasal Spray
(Atom ID: 6407265)
SY
Synonym (SY):
Cromolyn sodium 2 % / xylometazoline HCl 0.025 % Nasal Spray
(Atom ID: 6407266)
PT
Designated preferred name (PT):
Cromolyn sodium 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray
(Atom ID: 10296688)
FN
Full form of descriptor (FN):
Product containing precisely cromoglicate sodium 20 mg/1 mL and xylometazoline hydrochloride 250 microgram/1 mL conventional release nasal spray (clinical drug)
(Atom ID: 10311015)
SY